Company Profile

Pacific Biomarkers Inc (AKA: PBI ~ Pacific Biometrics Inc)
Profile last edited on: 12/14/2018      CAGE: 33ZM3      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

645 Elliott Avenue West Suite 300t
Seattle, WA 98119
   (206) 298-0068
Location: Multiple
Congr. District: 07
County: King

Public Profile

Spun out of the University of Washington Pacific Biomarkers, Inc, formerly known as Pacific Biometrics, was originally focused on lipids -providing specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. In 1994 Merchant House Scientific (cholesterol diagnostics) merged with Pacific Biometrics via a stock swap and preceding the firm's Public Offering in 1996. At the time, the firm was organizid around cardiovascular and osteoporosis diagnsotic products and laboratory services. Curently, Pacific Biomarkers offers biomarker testing services to pharmaceutical, biotech and in-vitro diagnostic (IVD) manufacturing companies through preclinical and Phase I-IV studies of drug and IVD development. Pacific Biomarkers provides accurate, reliable analyses, and responsive service to sponsors and investigative sites. Pacific Biomarkers collaborates with sponsors to develop, validate, improve analytical methods, and provide technical consultation for protocol design and provdes customized, project specific basis with the flexibity to meet clientneeds. In November 2018, Pacific Biomarkers acquired by Ampersand Capital Partners.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1999 1 NIH $85,320
Project Title: Development Of A Saliva Homocysteine Assay System
1997 1 NIH $98,451
Project Title: New Noninvasive Tests For Cholesterol And Apob In Saliva
1991 2 NIH $550,000
Project Title: Solid state enzyme-based immunosensors
1990 2 NIH $550,000
Project Title: Colorimetric Measurement of Milk Progesterone

Key People / Management

  Ronald R Helm -- President

  Timothy Carlson

  Byron Doneen